Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robb Knie currently holds 547,387 shares of Hoth Therapeutics, Inc. (HOTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robb Knie has been a net buyer of HOTH stock. They have purchased $24.6K and sold $0 worth of shares.
Robb Knie's most recent insider trade was on Aug 28, 2025, when they sold 310,744 shares at $1.21 per share.
Robb Knie serves as Executive at Hoth Therapeutics, Inc. (HOTH). They have executed 9 insider transactions totaling $24.6K over their tenure at the company.
Robb Knie holds the position of Executive at Hoth Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Robb Knie has shown a buying trading pattern, with $24.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robb Knie was on Aug 28, 2025, when they sold $376.0K worth of HOTH shares. This transaction involved 310,744 shares at $1.21 per share.
Robb Knie currently owns 547,387 shares of Hoth Therapeutics, Inc. (HOTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robb Knie's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robb Knie has 9 Form 4 filings on record as an insider at Hoth Therapeutics, Inc..
Set alerts for Robb Knie and 40,000+ other insiders.